Medulloblastoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Funding
• Clinical Trials
• Forums

Phase 2 Trial of PEP-CMV Vaccine Targeting CMV Antigen for Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Conditions:   High Grade Glioma;   Diffuse Intrinsic Pontine Glioma;   Recurrent Medulloblastoma Interventions:   Biological: PEP-CMV;   Drug: Temozolomide;   Biological: Tetanus Diphtheria Vaccine Sponsor:   Nationwide Children's Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2021 Category: Research Source Type: clinical trials